Nuvation Bio Class A stock price
누베이션 바이오NYSE:NUVB · New York Stock Exchange · Healthcare · sector #20Nuvation Bio Class A's chart data is dated 2026-10-08. There is no active technical signal. There are 6 published signal records.
Nuvation Bio Class A last closed at $4.95 (+1.85%) on 2026-10-08. Listed on New York Stock Exchange. Trailing 12 months PER is -11.5×. Its overall grade ranks 373 of 738 stocks in Healthcare.
About this company
Nuvation Bio Class A last closed at $4.95 (+1.85%) on 2026-10-08. Listed on New York Stock Exchange.
Details →Reported results
Position in sector
Healthcare · Overall B- · 373/738
Valuation grade B+
Related stocks
- PfizerCustomer
진행 중인 항암제 자산의 잠재적 라이선스·개발 협력 상대
- Bristol Myers SquibbCustomer
종양학 파이프라인의 잠재적 파트너/인수 후보로 자주 거론되는 대형 항암사
- MerckCompetitor
면역항암·표적항암 등 항암제 시장의 대형 경쟁사
ETFs holding this stock
SPDR S&P Pharmaceuticals ETF
Details →About Nuvation Bio Class A
- What technical signals does Nuvation Bio Class A (NUVB) have?
- Nuvation Bio Class A current technical signals: no active technical signal.
- Is Nuvation Bio Class A a cup-and-handle pattern?
- No. Nuvation Bio Class A has no valid Cup signal right now.
- What published figures are available for Nuvation Bio Class A?
- Market cap: $1.69B. Trailing 12 months PER: -11.5×. Latest quarter PBR: 6.80×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-09 dataset
Turn what you saw on this name into a strategy
Ask Q about Nuvation Bio Class A, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.